Literature DB >> 15130028

Feasibility and reliability of health-related quality of life measurements among tuberculosis patients.

M J Dion1, P Tousignant, J Bourbeau, D Menzies, K Schwartzman.   

Abstract

The dramatic global impact of tuberculosis on mortality has been well documented, but its impact on morbidity has not been well described. The emphasis on treatment of latent tuberculosis (TB) infection highlights the tradeoff between short-term decrements in health status from 'preventive' therapy, and long-term gains related to fewer cases of active TB. However, these changes in health status have not been characterized. As a first step, we examined the feasibility and reliability of administering two health status questionnaires, in a multicultural TB clinic setting. The Medical Outcomes Study SF-36 and the EuroQOL EQ-5D were self-administered during 3 weekly interviews. One hundred and eighty-six potentially eligible patients were identified, of whom 112 could be evaluated; 106 (57%) were confirmed eligible. Sixty-seven (63%) agreed to participate; 24 (36%) were women. Fifty-three participants (79%) were foreign-born, with median residence in Canada of 3.5 years. Fifty (75%) of the participants completed all study measurements: 25 were treated for latent TB, 17 for active TB, and eight had previous active TB. Cronbach's alpha coefficients ranged from 0.73 to 0.94 for the SF-36 domain scores. Intraclass correlation coefficients were 0.66 for the SF-36 physical component summary, 0.79 for the mental component summary, and 0.73 for the EQ-5D. These instruments appeared reliable in a highly selected group of TB patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15130028     DOI: 10.1023/B:QURE.0000021320.89524.64

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  32 in total

1.  Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations.

Authors:  K Dasgupta; K Schwartzman; R Marchand; T N Tennenbaum; P Brassard; D Menzies
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

2.  The Tuberculosis Trials Consortium: a model for clinical trials collaborations.

Authors: 
Journal:  Public Health Rep       Date:  2001       Impact factor: 2.792

Review 3.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

4.  Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome.

Authors:  C Myers; D Wilks
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

5.  Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders.

Authors:  D E Beaton; S Hogg-Johnson; C Bombardier
Journal:  J Clin Epidemiol       Date:  1997-01       Impact factor: 6.437

6.  Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.

Authors:  W M Hopman; T Towheed; T Anastassiades; A Tenenhouse; S Poliquin; C Berger; L Joseph; J P Brown; T M Murray; J D Adachi; D A Hanley; E Papadimitropoulos
Journal:  CMAJ       Date:  2000-08-08       Impact factor: 8.262

7.  Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis.

Authors:  K Schwartzman; D Menzies
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

8.  How do scores on the EuroQol relate to scores on the SF-36 after stroke?

Authors:  P J Dorman; M Dennis; P Sandercock
Journal:  Stroke       Date:  1999-10       Impact factor: 7.914

9.  Reliability and validity of the EuroQol in patients with osteoarthritis of the knee.

Authors:  M Fransen; J Edmonds
Journal:  Rheumatology (Oxford)       Date:  1999-09       Impact factor: 7.580

Review 10.  When tuberculosis treatment fails. A social behavioral account of patient adherence.

Authors:  E Sumartojo
Journal:  Am Rev Respir Dis       Date:  1993-05
View more
  33 in total

1.  The impact of tuberculosis on health utility: a longitudinal cohort study.

Authors:  Melissa Bauer; Sara Ahmed; Andrea Benedetti; Christina Greenaway; Marek Lalli; Allison Leavens; Dick Menzies; Claudia Vadeboncoeur; Bilkis Vissandjée; Ashley Wynne; Kevin Schwartzman
Journal:  Qual Life Res       Date:  2014-11-13       Impact factor: 4.147

2.  Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.

Authors:  D Shepardson; S M Marks; H Chesson; A Kerrigan; D P Holland; N Scott; X Tian; A S Borisov; N Shang; C M Heilig; T R Sterling; M E Villarino; W R Mac Kenzie
Journal:  Int J Tuberc Lung Dis       Date:  2013-12       Impact factor: 2.373

3.  Health-related quality of life among pulmonary tuberculosis patients in Pakistan.

Authors:  Saniya Saleem; Amyn A Malik; Asma Ghulam; Junaid Ahmed; Hamidah Hussain
Journal:  Qual Life Res       Date:  2018-08-02       Impact factor: 4.147

4.  Priorities for screening and treatment of latent tuberculosis infection in the United States.

Authors:  Benjamin P Linas; Angela Y Wong; Kenneth A Freedberg; C Robert Horsburgh
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

5.  Assessment of Health-related Quality of Life among Patients with Tuberculosis in Hamadan, Western Iran.

Authors:  Mojgan Mamani; Mohammad Mahdi Majzoobi; Sahar Mousavi Ghahfarokhi; Farzaneh Esna-Ashari; Fariba Keramat
Journal:  Oman Med J       Date:  2014-03

6.  Health-related quality of life: A neglected aspect of pulmonary tuberculosis.

Authors:  Ashutosh N Aggarwal
Journal:  Lung India       Date:  2010-01

7.  Health-related quality of life of inpatients and outpatients with TB in rural Malawi.

Authors:  Y Jo; I Gomes; H Shin; A Tucker; L G Ngwira; R E Chaisson; E L Corbett; D W Dowdy
Journal:  Int J Tuberc Lung Dis       Date:  2020-11-01       Impact factor: 2.373

8.  Factors associated with health-related quality of life among pulmonary tuberculosis patients in Manila, the Philippines.

Authors:  Shoichi Masumoto; Taro Yamamoto; Akihiro Ohkado; Shoji Yoshimatsu; Aurora G Querri; Yasuhiko Kamiya
Journal:  Qual Life Res       Date:  2013-11-22       Impact factor: 4.147

9.  Psychometric testing of the short version of the world health organization quality of life (WHOQOL-BREF) questionnaire among pulmonary tuberculosis patients in Taiwan.

Authors:  Wei-Sheng Chung; Yu-Ling Lan; Ming-Chin Yang
Journal:  BMC Public Health       Date:  2012-08-09       Impact factor: 3.295

10.  Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes.

Authors:  A Kowada
Journal:  Epidemiol Infect       Date:  2016-07-14       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.